Clinical trial · Interventional
Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer
Diagnostic and Prognostic Values of EUS-FNA Specimens and Circulating Exosomal Small RNA in Patients With Pancreatic Cancer
NCT04636788CI-TRIAL-00048362unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is for the verification of biomarkers for pancreatic cancer treatment using small RNA liquid biopsy, combined with EUS-FNA tissues.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreas Adenocarcinoma | Pancreatic Adenocarcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Venous sampling | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- pancreatic cancer group
- description
- pancreatic cancer, anticipated participants: 68 other pancreatic lesions including MCN, SCN, IPMN, SPN without malignant pathological finding chronic pancreatitis cholangiocarcinoma healthy control anticipated participants: 34
- interventionNames
- Procedure: Venous sampling
Primary outcomes (2)
- measure
- senstivity
- timeFrame
- up to 8 weeks
- description
- sensitivity of exo-sRNA
- measure
- specificity
- timeFrame
- up to 8 weeks
- description
- specificity of exo-sRNA to differentiate between PAAD and other benigh or malignant pancreatic occupying lesions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * age \>18 * pancreatic cancer patients * pancreatic lesions other than PAAD * chronic pancreatitis * cholangiocarcinoma Exclusion Criteria: * diagnosed with other pathological types of cancer * treated with chemo/radio/surgery previously
References
Publications (0)
Data not yet available
No reference posted for this study.